Innovation1 Biotech Inc.
IVBT · OTC
2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $17 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $18 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 50% | – |
| EBITDA | -$0 | -$0 | -$4 | -$0 |
| % Margin | – | – | -4,136.5% | – |
| Net Income | -$0 | -$0 | -$4 | -$0 |
| % Margin | – | – | -4,247.1% | – |
| EPS Diluted | -0.023 | -0.023 | -0.23 | -0.03 |
| % Growth | -1.3% | 90% | -666.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |